Are endogenous feline leukemia viruses really endogenous?

Veterinary Immunology and Immunopathology

Volumn 143, Issue 3-4, 2011, Pages 325-331

  Stewart, H ^a   Jarrett, O ^a   Hosie, M J ^a   Willett, B J ^a  

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

Author keywords

Endogenous retrovirus; Feline leukemia virus; LTRs; RNA co packaging

Indexed keywords

VIRUS PROTEIN;

ARTICLE; CAT; FELINE LEUKEMIA VIRUS; GENE SEQUENCE; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; RETROVIRUS; VIRION; VIRUS GENOME; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ANIMALS; CATS; CELL LINE; CLONING, MOLECULAR; DNA, VIRAL; GENOME, VIRAL; IMMUNOBLOTTING; LEUKEMIA VIRUS, FELINE; LEUKEMIA, FELINE; POLYMERASE CHAIN REACTION; PROVIRUSES; RECEPTORS, VIRUS; RNA, VIRAL; VIRAL PROTEINS;

CERCOPITHECINE HERPESVIRUS 1; FELINE LEUKEMIA VIRUS; FELIS CATUS; SUBGROUP A; SUBGROUP B;

EID: 80052377357     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.06.011     Document Type: Article

References (59)

1. Abujamra A.L., Faller D.V., Ghosh S.K. Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication. Virology 2003, 309:294-305.
2. Anderson M.M., Lauring A.S., Burns C.C., Overbaugh J. Identification of a cellular cofactor required for infection by feline leukemia virus. Science 2000, 287:1828-1830.
3. Anderson M.M., Lauring A.S., Robertson S., Dirks C., Overbaugh J. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses. J. Virol. 2001, 75:10563-10572.
4. Athas G.B., Choi B., Prabhu S., Lobelle-Rich P.A., Levy L.S. Genetic determinants of feline leukemia virus-induced multicentric lymphomas. Virology 1995, 214:431-438.
5. Bae Y., Kingsman S.M., Kingsman A.J. Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J. Virol. 1997, 71:2092-2099.
6. Benveniste R.E., Todaro G.J. Segregation of RD-114 AND FeL-V-related sequences in crosses between domestic cat and leopard cat. Nature 1975, 257:506-508.
7. Berry B.T., Ghosh A.K., Kumar D.V., Spodick D.A., Roy-Burman P. Structure and function of endogenous feline leukemia virus long terminal repeats and adjoining regions. J. Virol. 1988, 62:3631-3641.
8. Boomer S., Eiden M., Burns C.C., Overbaugh J. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition. J. Virol. 1997, 71:8116-8123.
9. Busch M.P., Devi B.G., Soe L.H., Perbal B., Baluda M.A., Roy-Burman P. Characterization of the expression of cellular retrovirus genes and oncogenes in feline cells. Hematol. Oncol. 1983, 1:61-75.
10. Casey J.W., Roach A., Mullins J.I., Burck K.B., Nicolson M.O., Gardner M.B., Davidson N. The U3 portion of feline leukemia virus DNA identifies horizontally acquired proviruses in leukemic cats. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:7778-7782.
11. Chandhasin C., Lobelle-Rich P., Levy L.S. Feline leukemia virus LTR variation and disease association in a geographical and temporal cluster. J. Gen. Virol. 2004, 85:2937-2942.
12. Coffin J.M., Stoye J.P., Frankel W.N. Genetics of endogenous murine leukemia viruses. Ann. N. Y. Acad. Sci. 1989, 567:39-49.
13. Corden J., Wasylyk B., Buchwalder A., Sassone-Corsi P., Kedinger C., Chambon P. Promoter sequences of eukaryotic protein-coding genes. Science 1980, 209:1406-1414.
14. Elder J.H., McGee J.S., Munson M., Houghten R.A., Kloetzer W., Bittle J.L., Grant C.K. Localization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies. J. Virol. 1987, 61:8-15.
15. Fan H. Leukemogenesis by Moloney murine leukemia virus: a multistep process. Trends Microbiol. 1997, 5:74-82.
16. Ghosh S.K., Faller D.V. Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1. J. Virol. 1999, 73:4931-4940.
17. Ghosh S.K., Roy-Burman P., Faller D.V. Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression. J. Virol. 2000, 74:9742-9748.
18. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977, 36:59-74.
19. Grosschedl R., Birnstiel M.L. Spacer DNA sequences upstream of the T-A-T-A-A-A-T-A sequence are essential for promotion of H2A histone gene transcription in vivo. Proc. Natl. Acad. Sci. U.S.A. 1980, 77:7102-7106.
20. Hisasue M., Nagashima N., Nishigaki K., Fukuzawa I., Ura S., Katae H., Tsuchiya R., Yamada T., Hasegawa A., Tsujimoto H. Myelodysplastic syndromes and acute myeloid leukemia in cats infected with feline leukemia virus clone33 containing a unique long terminal repeat. Int. J. Cancer 2009, 124:1133-1141.
21. Jarrett O., Hardy W.D., Golder M.C., Hay D. The frequency of occurrence of feline leukemia virus subgroups in cats. Int. J. Cancer 1978, 21:334-337.
22. Jarrett O., Laird H.M., Hay D. Growth of feline leukemia virus in human, canine and porcine cells. Comparative Leukemia Research 1969, 387-392. Karger, Basel/Munchen/Paris/New York. R.M. Dutcher (Ed.).
23. Jarrett O., Laird H.M., Hay D. Determinants of the host range of feline leukemia viruses. J. Gen. Virol. 1973, 20:169-175.
24. Jarrett O., Russell P.H. Differential growth and transmission in cats of feline leukemia viruses of subgroups A and B. Int. J. Cancer 1978, 21:466-472.
25. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 1992, 66:2232-2239.
26. Koshy R., Gallo R.C., Wong-Staal F. Characterization of the endogenous feline leukemia virus-related DNA sequences in cats and attempts to identify exogenous viral sequences in tissues of virus-negative leukemic animals. Virology 1980, 103:434-445.
27. Lauring A.S., Anderson M.M., Overbaugh J. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants. J. Virol. 2001, 75:8888-8898.
28. Levy L.S., Lobelle-Rich P.A., Overbaugh J. flvi-2, a target of retroviral insertional mutagenesis in feline thymic lymphosarcomas, encodes bmi-1. Oncogene 1993, 8:1833-1838.
29. Matsumoto Y., Momoi Y., Watari T., Goitsuka R., Tsujimoto H., Hasegawa A. Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and nonneoplastic diseases. Virology 1992, 189:745-749.
30. McDougall A.S., Terry A., Tzavaras T., Cheney C., Rojko J., Neil J.C. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. J. Virol. 1994, 68:2151-2160.
31. Mendoza R., Anderson M.M., Overbaugh J. A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A. J. Virol. 2006, 80:3378-3385.
32. Neil J.C., Fulton R., Rigby M., Stewart M. Feline leukemia virus: generation of pathogenic and oncogenic variants. Curr. Top. Microbiol. Immunol. 1991, 171:67-93.
33. Niman H.L., Akhavi M., Gardner M.B., Stephenson J.R., Roy-Burman P. Differential expression of two distinct endogenous retrovirus genomes in developing tissues of the domestic cat. J. Natl. Cancer Inst. 1980, 64:587-594.
34. Nishigaki K., Okuda M., Endo Y., Watari T., Tsujimoto H., Hasegawa A. Structure and function of the long terminal repeats of feline leukemia viruses derived from naturally occurring acute myeloid leukemias in cats. J. Virol. 1997, 71:9823-9827.
35. Nunberg J.H., Rodgers G., Gilbert J.H., Snead R.M. Method to map antigenic determinants recognized by monoclonal antibodies: localization of a determinant of virus neutralization on the feline leukemia virus envelope protein gp70. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:3675-3679.
36. Ohashi T., Boggs S., Robbins P., Bahnson A., Patrene K., Wei F.S., Wei J.F., Li J., Lucht L., Fei Y., et al. Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:11332-11336.
37. Okabe H., DuBuy J., Gilden R.V., Gardner M.B. A portion of the feline leukemia virus genome is not endogenous in cat cells. Int. J. Cancer 1978, 22:70-78.
38. Okabe H., Twiddy E., Gilden R.V., Hatanaka M., Hoover E.A., Olsen R.G. FeLV-related sequences in DNA from a FeLV-free cat colony. Virology 1976, 69:798-801.
39. Overbaugh J., Riedel N., Hoover E.A., Mullins J.I. Transduction of endogenous envelope genes by feline leukemia virus in vitro. Nature 1988, 332:731-734.
40. Pandey R., Ghosh A.K., Kumar D.V., Bachman B.A., Shibata D., Roy-Burman P. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses. J. Virol. 1991, 65:6495-6508.
41. Proudfoot N.J. Eukaryotic promoters?. Nature 1979, 279:376.
42. Rigby M.A., Rojko J.L., Stewart M.A., Kociba G.J., Cheney C.M., Rezanka L.J., Mathes L.E., Hartke J.R., Jarrett O., Neil J.C. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukemia viruses with chimeric envelope genes. J. Gen. Virol. 1992, 73(Pt 11):2839-2847.
43. Roca A.L., Nash W.G., Menninger J.C., Murphy W.J., O'Brien S.J. Insertional polymorphisms of endogenous feline leukemia viruses. J. Virol. 2005, 79:3979-3986.
44. Roca A.L., Pecon-Slattery J., O'Brien S.J. Genomically intact endogenous feline leukemia viruses of recent origin. J. Virol. 2004, 78:4370-4375.
45. Rudra-Ganguly N., Ghosh A.K., Roy-Burman P. Retrovirus receptor PiT-1 of the Felis catus. Biochim. Biophys. Acta 1998, 1443:407-413.
46. Sarma P.S., Log T. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. Virology 1973, 54:160-169.
47. Sheets R.L., Pandey R., Jen W.C., Roy-Burman P. Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas. J. Virol. 1993, 67:3118-3125.
48. Sheets R.L., Pandey R., Klement V., Grant C.K., Roy-Burman P. Biologically selected recombinants between feline leukemia virus (FeLV) subgroup A and an endogenous FeLV element. Virology 1992, 190:849-855.
49. Soe L.H., Devi B.G., Mullins J.I., Roy-Burman P. Molecular cloning and characterization of endogenous feline leukemia virus sequences from a cat genomic library. J. Virol. 1983, 46:829-840.
50. Soe L.H., Shimizu R.W., Landolph J.R., Roy-Burman P. Molecular analysis of several classes of endogenous feline leukemia virus elements. J. Virol. 1985, 56:701-710.
51. Stewart M.A., Warnock M., Wheeler A., Wilkie N., Mullins J.I., Onions D.E., Neil J.C. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J. Virol. 1986, 58:825-834.
52. Sugai J., Eiden M., Anderson M.M., Van Hoeven N., Meiering C.D., Overbaugh J. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2. J. Virol. 2001, 75:6841-6849.
53. Takeuchi Y., Vile R.G., Simpson G., O'Hara B., Collins M.K., Weiss R.A. Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J. Virol. 1992, 66:1219-1222.
54. Tandon R., Cattori V., Willi B., Lutz H., Hofmann-Lehmann R. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays. Vet. Immunol. Immunopathol. 2008, 123:129-133.
55. Tsatsanis C., Fulton R., Nishigaki K., Tsujimoto H., Levy L., Terry A., Spandidos D., Onions D., Neil J.C. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement. J. Virol. 1994, 68:8296-8303.
56. Tzavaras T., Stewart M., McDougall A., Fulton R., Testa N., Onions D.E., Neil J.C. Molecular cloning and characterization of a defective recombinant feline leukemia virus associated with myeloid leukemia. J. Gen. Virol. 1990, 71(Pt 2):343-354.
57. Weng H., Choi S.Y., Faller D.V. The Moloney leukemia retroviral long terminal repeat trans-activates AP-1-inducible genes and AP-1 transcription factor binding. J. Biol. Chem. 1995, 270:13637-13644.
58. Yee J.K., Miyanohara A., LaPorte P., Bouic K., Burns J.C., Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:9564-9568.
59. Yin P.D., Hu W.S. RNAs from genetically distinct retroviruses can copackage and exchange genetic information in vivo. J. Virol. 1997, 71:6237-6242.